New transplant approach aims to tame tough lymphoma

NCT ID NCT03922724

First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 28 times

Summary

This study tests whether a stem cell transplant from a healthy donor can control peripheral T-cell lymphoma in people aged 12 and older whose cancer hasn't responded to standard treatments. The goal is to see if newer ways of preparing the body for transplant cause fewer side effects while still helping manage the disease. Participants receive chemotherapy or antibody therapy before the transplant and must take drugs for about two months afterward.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE SYSTEM DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-••••

  • National Marrow Donor Program

    ENROLLING_BY_INVITATION

    Minneapolis, Minnesota, 55401, United States

Conditions

Explore the condition pages connected to this study.